Calcimimetics have had no impact on the indications for surgery of tertiary hyperparathyroidism

dc.contributor.author	Ruiz, José
dc.contributor.author	Ríos-Zambudio, Antonio
dc.contributor.author	Rodríguez-González, José-Manuel
dc.contributor.author	Llorente-Vinas, Santiago
dc.contributor.author	Jimeno-García, Luisa
dc.contributor.author	Parrilla-Paricio, Pascual
dc.date.accessioned	2026-02-12T12:08:19Z
dc.date.available	2026-02-12T12:08:19Z
dc.date.issued	2017-11
dc.identifier.citation	Ruiz J, Ríos A, Rodríguez JM, Llorente S, Jimeno L, Parrilla P. Calcimimetics have had no impact on the indications for surgery of tertiary hyperparathyroidism. Nefrología (English Edition). noviembre de 2017;37(6):651-2.
dc.identifier.issn	0211-6995
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/24263
dc.language.iso	eng
dc.publisher	SOC ESPANOLA NEFROLOGIA DR RAFAEL MATESANZ
dc.rights	Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.title	Calcimimetics have had no impact on the indications for surgery of tertiary hyperparathyroidism
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	29122212
dc.relation.publisherversion	https://linkinghub.elsevier.com/retrieve/pii/S2013251417301773
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.identifier.doi	10.1016/j.nefroe.2017.10.008
dc.journal.title	Nefrología
dc.identifier.essn	1989-2284